Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Olivier Morel"'
Autor:
Clément Bouron, Clara Mathie, Valérie Seegers, Olivier Morel, Pascal Jézéquel, Hamza Lasla, Camille Guillerminet, Sylvie Girault, Marie Lacombe, Avigaelle Sher, Franck Lacoeuille, Anne Patsouris, Aude Testard
Publikováno v:
Cancers, Vol 14, Iss 3, p 637 (2022)
(1) Background: triple-negative breast cancer (TNBC) remains a clinical and therapeutic challenge primarily affecting young women with poor prognosis. TNBC is currently treated as a single entity but presents a very diverse profile in terms of progno
Externí odkaz:
https://doaj.org/article/142e8ed7a4644b948f9f75a83fdfba12
Autor:
Maelle Le Thiec, Aude Testard, Ludovic Ferrer, Camille Guillerminet, Olivier Morel, Bruno Maucherat, Daniela Rusu, Sylvie Girault, Marie Lacombe, Hadji Hamidou, Véronique Guérin Meyer, Emmanuel Rio, Sandrine Hiret, Françoise Kraeber-Bodéré, Loïc Campion, Caroline Rousseau
Publikováno v:
Cancers, Vol 12, Iss 6, p 1512 (2020)
Due to the heterogeneity of tumour mass segmentation methods and lack of consensus, our study evaluated the prognostic value of pretherapeutic positron emission tomography with fluorodeoxyglucose (FDG-PET) metabolic parameters using different segment
Externí odkaz:
https://doaj.org/article/e825956f2cd6438997af480e34ba9e16
Autor:
Clément, Bouron, Clara, Mathie, Valérie, Seegers, Olivier, Morel, Pascal, Jézéquel, Hamza, Lasla, Camille, Guillerminet, Sylvie, Girault, Marie, Lacombe, Avigaelle, Sher, Franck, Lacoeuille, Anne, Patsouris, Aude, Testard
Publikováno v:
Cancers. 14(3)
(1) Background: triple-negative breast cancer (TNBC) remains a clinical and therapeutic challenge primarily affecting young women with poor prognosis. TNBC is currently treated as a single entity but presents a very diverse profile in terms of progno
Autor:
Sylvie Girault, Aude Testard, Ludovic Ferrer, Sandrine Hiret, Olivier Morel, Maelle Le Thiec, Françoise Kraeber-Bodéré, Bruno Maucherat, Loïc Campion, D. Rusu, Camille Guillerminet, Emmanuel Rio, Hadji Hamidou, Véronique Guérin Meyer, Marie Lacombe, Caroline Rousseau
Publikováno v:
Cancers
Cancers, MDPI, 2020, 12 (6), pp.1512. ⟨10.3390/cancers12061512⟩
Volume 12
Issue 6
Cancers, 2020, 12 (6), pp.1512. ⟨10.3390/cancers12061512⟩
Cancers, Vol 12, Iss 1512, p 1512 (2020)
Cancers, MDPI, 2020, 12 (6), pp.1512. ⟨10.3390/cancers12061512⟩
Volume 12
Issue 6
Cancers, 2020, 12 (6), pp.1512. ⟨10.3390/cancers12061512⟩
Cancers, Vol 12, Iss 1512, p 1512 (2020)
International audience; Due to the heterogeneity of tumour mass segmentation methods and lack of consensus, our study evaluated the prognostic value of pretherapeutic positron emission tomography with fluorodeoxyglucose (FDG-PET) metabolic parameters